American Vanguard vs Scotts Miracle-Gro
AVD and SMG side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AVD and SMG compare
Scotts Miracle-Gro is the larger company, worth 151 times as much as American Vanguard ($3.8B against $25.1M).
Scotts Miracle-Gro grew revenue faster over the last twelve months (4.6% versus −5.8% for American Vanguard).
Scotts Miracle-Gro keeps more of each dollar of sales as profit, with a net margin of 2.1% compared with −12.0% at American Vanguard.
Scotts Miracle-Gro pays a dividend yielding 4.1%; American Vanguard does not pay one.
Scotts Miracle-Gro scores higher on the StockData Score (12 against 3 for American Vanguard), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AVD | SMG |
|---|---|---|
| Size and price | ||
| Market cap | $25.1M | $3.8B |
| Share price | $0.879 | $65.04 |
| Change, 1 year | −82.6% | 14.2% |
| Change, 5 years | −94.5% | −60.8% |
| Beta (5Y) | 0.91 | 1.30 |
| Employees | 739 | 5,200 |
| StockData Score | ||
| Total score | 3 | 12 (better) |
| Valuation score | 1 | 2 (better) |
| Growth score | 1 | 3 (better) |
| Performance score | 0 | 3 (better) |
| Health score | 1 | 1 |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | – | 53.8× |
| P/S | 0.1× (better) | 1.1× |
| EV/EBITDA | – | 15.4× |
| P/FCF | – | 14.4× |
| FCF yield | – | 7.0% |
| Fair value | – | $51.84 |
| Margin of safety | – | −25.5% |
| Growth | ||
| Revenue growth (TTM) | −5.8% | 4.6% (better) |
| Revenue growth, 5Y average | 2.3% (better) | −3.7% |
| EPS growth, 5Y average | – | −18.4% |
| Profitability | ||
| Gross margin | 28.4% | 31.8% (better) |
| Operating margin | −5.7% | 11.0% (better) |
| Net margin | −12.0% | 2.1% (better) |
| FCF margin | – | 7.6% |
| Return on invested capital | – | 12.3% |
| Financial health | ||
| Net debt / EBITDA | – | 5.45 |
| Interest coverage | −1.0× | 3.4× (better) |
| Current ratio | 2.02 (better) | 1.21 |
| Altman Z-score | 1.30 | 2.44 (better) |
| Piotroski F-score | 5 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 4.1% |
| Payout ratio | – | 209% |
| Years of dividend growth | – | 0 |
| Dividend growth, 5Y average | – | −18.5% |
| Buyback yield | – | 0.32% |
| Shareholder yield | 0.00% | 4.4% (better) |
| Ownership | ||
| Held by institutions | 51.6% | 86.5% |
| Held by insiders | 6.2% | 53.4% |
| Insider net buying, 12 months | −$987K (better) | −$5.4M |
| Short interest, % of float | 1.1% | 19.0% |
Go deeper
- AVD stock overview
- AVD income statement
- AVD valuation and score
- SMG stock overview
- SMG income statement
- SMG valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.